Privacy and Legal Notice

CIAC INFORMATION BULLETIN

S-321: Novell iPrint Client ActiveX Vulnerabilities

[US-CERT Vulnerability Note VU#145313]

June 19, 2008 16:00 GMT

PROBLEM: The Novell iPrint Client ActiveX control contains multiple stack buffer overflows, which can allow a remote, unauthenticated attacker to execute arbitrary code on a vulnerable system.
PLATFORM: Novell iPrint
DAMAGE: Execute arbitrary code.
SOLUTION: Upgrade to the appropriate version.

VULNERABILITY
ASSESSMENT:
The risk is MEDIUM. By convincing a user to view a specially crafted HTMl document (e.g., a web page or an HTML email message or attachment), an attacker may be able to execute arbitrary code with the privileges of the user.

CVSS 2 BASE SCORE:
   TEMPORAL SCORE:
   VECTOR:
6.4
5.3
(AV:N/AC:L/Au:N/C:P/I:P/A:N/E:F/RL:OF/RC:C)

LINKS:  
  CIAC BULLETIN: http://www.ciac.org/ciac/bulletins/s-321.shtml
  ORIGINAL BULLETIN: http://www.kb.cert.org/vuls/id/145313
  ADDITIONAL LINKS: http://www.kb.cert.org/vuls/id/315107
http://support.novell.com/docs/Readmes/InfoDocument/patchbuilder/readme_5028061.html

[***** Start US-CERT Vulnerability Note VU#145313 *****]

Vulnerability Note VU#858993

Deterministic Network Enhancer privilege escalation vulnerability

Overview

The Deterministic Network driver contains a privilege escalation vulnerability, which can allow a local attacker to execute code with kernel privileges.

I. Description

Deterministic Networks provides a product called Deterministic Network Enhancer (DNE), which extends the Microsoft Windows networking stack. DNE is packaged with multiple applications, including the Cisco VPN Client. The DNE driver, which is provided by dne2000.sys, is vulnerable to privilege escalation. By making a certain ioctl to the DNE device driver, it is possible to execute code with windows kernel privileges.

II. Impact

A local attacker may be able to execute code with windows kernel privileges.

III. Solution

Apply an update

This issue is addressed in dne2000.sys version 3.21.12.17902. This driver is available from the DNE support page.

Cisco Windows VPN Client users should install version 5.0.03.0530, as specified in Cisco Support document CSCsm25860.

For other products that provide the DNE driver, please check with the vendor for updates.

Systems Affected

Vendor Status Date Updated
Blue Coat Systems Vulnerable 19-Jun-2008
Cisco Systems, Inc. Vulnerable 18-Jun-2008
Deterministic Networks, Inc Vulnerable 18-Jun-2008
SafeNet Vulnerable 19-Jun-2008

References


http://www.digit-labs.org/files/exploits/dne2000-call.c
http://www.deterministicnetworks.com/support/dnesupport.asp
http://tools.cisco.com/Support/BugToolKit/search/getBugDetails.do?method=fetchBugDetails&bugId=CSCsm25860
http://secunia.com/advisories/30728/
http://secunia.com/advisories/30753/
http://secunia.com/advisories/30744/
http://secunia.com/advisories/30747/

Credit

This vulnerability was reported by mu-b at Digit-Labs.

This document was written by Will Dormann.

Other Information

Date Public 06/17/2008
Date First Published 06/18/2008 11:16:29 AM
Date Last Updated 06/19/2008
CERT Advisory  
CVE Name  
US-CERT Technical Alerts  
Metric 22.50
Document Revision 6

[***** End US-CERT Vulnerability Note VU#145313 *****]


CIAC wishes to acknowledge the contributions of US-CERT for the information contained in this bulletin.
CIAC services are available to DOE, DOE Contractors, and the NIH. CIAC can be contacted at:
    Voice:          +1 925-422-8193 (7 x 24)
    FAX:            +1 925-423-8002
    STU-III:        +1 925-423-2604
    E-mail:          ciac@ciac.org
    World Wide Web:  http://www.ciac.org/
    Anonymous FTP:   ftp.ciac.org

This document was prepared as an account of work sponsored by an agency of the United States Government. Neither the United States Government nor the University of California nor any of their employees, makes any warranty, express or implied, or assumes any legal liability or responsibility for the accuracy, completeness, or usefulness of any information, apparatus, product, or process disclosed, or represents that its use would not infringe privately owned rights. Reference herein to any specific commercial products, process, or service by trade name, trademark, manufacturer, or otherwise, does not necessarily constitute or imply its endorsement, recommendation or favoring by the United States Government or the University of California. The views and opinions of authors expressed herein do not necessarily state or reflect those of the United States Government or the University of California, and shall not be used for advertising or product endorsement purposes.
UCRL-MI-119788
[Privacy and Legal Notice]